Gael Ltd, a wholly owned subsidiary of Ideagen PLC, is to exhibit once again at an industry leading conference for physical and mental health. Representatives from the company will attend the 11th Annual UK Clinical Research Facilities Conference (UK CRF) between 9th and 10th July.
The conference – held in the Royal College of Physicians premises in London’s Regent’s Park – is a platform for scientists and clinicians to gain the insights needed to bring new medicines and technologies from the laboratory bench to the patient. Speakers from both physical and mental health will explore how CRFs can best support the future clinical research agenda.
Deborah Scott, Ideagen’s Life Sciences Account Manager, said: “We are delighted to be exhibiting once again at this event which was such a success in 2014.
“This is a vitally important conference which provides scientists and clinicians with a chance to discuss changes in the industry and how best they can enhance both the industry and patient experience going forward.”
Ideagen Plc are listed on The London Stock Exchange AIM market and specialise in compliance based information management software. The Group develops software products designed to enhance the quality, safety and patient experience within healthcare and life science industries.
Entitled ‘Looking Through the Glass’, the UK CRF conference is co-hosted by the National Institute for Health Research Guy's and St Thomas' Clinical Research Facility – an Ideagen customer – and the NIHR/Wellcome Trust King’s CRF.
The theme for the event will “set the scene for the conference in which the CRFs are providing the ‘looking glass’ through which scientists and clinicians gain the insights needed to bring new medicines and technologies from the laboratory bench to the patient.” It’s hoped that the theme will provide a platform for speakers from both physical and mental health to explore how CRFs can best support the future clinical research agenda.
Speakers over the two days include Dr David Vaughn, Head of External R&D, North America Vaccine Discovery and Development, GSK, Professor David Edwards, Director of the Centre for the Developing Brain, Guy’s and St Thomas’ and Professor Dame Sally Davies, Chief Medical Officer, Department of Health.